Catalyst Wire Dossier Catalyst Wire Dossier

Moexipril HCl/Hydrochlorothiazide 15/25 mg tablets

Moexipril hydrochloride; hydrochlorothiazide · Teva Pharmaceuticals USA
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Moexipril HCl/Hydrochlorothiazide 15/25 mg tablets, covering 2009-08-18 to 2009-08-18. Get the full timeline:

Most recent: Clinical Trial Update: Moexipril HCL/Hydrochlorothiazide 15/25 mg Tablets Under Fasting Conditions [Phase 1]

See pricing